I-4-Amino-3-Chlorophenol Hydrochloride CAS 52671-64-4 Lenvatinib Mesylate Intermediate Purity >98.0% (HPLC)
I-Ruifu Chemical Supply Lenvatinib Mesylate Intermediates With High Purity
I-Lenvatinib Mesylate CAS 857890-39-2
4-Chloro-7-Methoxyquinoline-6-Carboxamide CAS 417721-36-9
I-Desquinolinyl Lenvatinib;1-(2-Chloro-4-Hydroxyphenyl)-3-Cyclopropylurea CAS 796848-79-8
I-Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate CAS 205448-65-3
I-Methyl 4-Amino-2-Methoxybenzoate CAS 27492-84-8
5-(Methoxymethylene)-2,2-Dimethyl-1,3-Dioxane-4,6-Dione CAS 15568-85-1
I-4-Amino-3-Chlorophenol CAS 17609-80-2
I-4-Amino-3-Chlorophenol Hydrochloride CAS 52671-64-4
I-Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4
Igama Lekhemikhali | I-4-Amino-3-Chlorophenol Hydrochloride |
Omqondofana | I-2-Chloro-4-Hydroxyaniline Hydrochloride |
Inombolo ye-CAS | 618-89-3 |
Inombolo yeCAT | I-RF-PI1969 |
Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani |
I-Molecular Formula | C6H6ClNO·HCl |
Isisindo samangqamuzana | 180.03 |
I-Melting Point | 254.0~256.0℃(dec.)(lit.) |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | I-Brown Solid Powder |
Ukuhlanzeka / Indlela Yokuhlaziya | >98.0% (HPLC) |
Ukuhlanzeka / Indlela Yokuhlaziya | 97.5~102.5% (Titration by AgNO3) |
Ukulahlekelwa Ekumisweni | <0.50% |
Izinsalela ekushiseni | <0.30% |
Ukungcola Okuphelele | <2.00% |
I-Infrared Spectrum | Ivumelana Nesakhiwo |
I-Proton NMR Spectrum | Ivumelana Nesakhiwo |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | I-Intermediate ye-Lenvatinib Mesylate (CAS: 857890-39-2) |
Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama
I-4-Amino-3-Chlorophenol Hydrochloride (i-CAS: 52671-64-4) iphakathi kwe-Lenvatinib Mesylate (CAS: 857890-39-2).I-Lenvatinib (igama lokuhweba elithi Lenvima) iyisidakamizwa esilwa nomdlavuza ekwelapheni izinhlobo ezithile zomdlavuza wegilo, futhi okungenzeka nakwamanye umdlavuza.I-Lenvatinib isetshenziselwa ukwelapha umdlavuza wegilo ohlukanisiwe okungenzeka ukuthi uphindaphindeka endaweni noma we-metastatic, oqhubekayo, futhi ongaphenduli ekwelapheni nge-radioiodine (radioiodine) .I-LENVATINIB umuthi oqondisa amaprotheni kumaseli omdlavuza futhi uvimbele amangqamuzana omdlavuza ukuthi angakhuli.Isetshenziselwa ukwelapha umdlavuza wegilo kanye nomdlavuza wezinso.Qhathanisa ama-kinase inhibitors.I-Lenvatinib iyi-multi-target inhibitor ye-VEGFR2 ne-VEGFR3 ene-IC50 ye-4 nM kanye ne-5.2 nM, ngokulandelanayo.